With or without insurance
Receive GLP-1 medications, including Zepbound™, at an affordable price with or without insurance.
20% Average Weight Loss
Zepbound™ patients lose 20% of their body weight on average in under a year.
Science-Backed
GLP-1 medications, like Zepbound™ are FDA-approved for type 2 diabetes and have proven effective for weight loss.
Zepbound™ is a GLP-1/GIP medication FDA-approved to treat obesity & facilitate weight loss. It has been shown to help people lose an average of 20% of their body weight.*
FDA-approved
2.5 mg per injection
*This estimate derives from Eli Lilly’s SURMOUNT-4 clinical trial results which showed 20% average weight loss over 36 weeks among people utilized a maximum tolerated dose of 10 mg or 15 mg once-weekly. The starting dose of 2.5 mg Zepbound was increased by 2.5 mg every four weeks until maximum tolerated dose was achieved.
Tirzepatide, active ingredient in Zepbound™, is available if Zepbound™ not covered by insurance
$25 for 4 pens Zepbound
One-time payment in full at checkout. Not a subscription.